ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

REGN Regeneron Pharmaceuticals Inc

667.40
-13.21 (-1.94%)
Last Updated: 19:11:20
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 3.16B3.16B3.36B3.43B3.15B3.55B3.72B3.79B
Operating Income 946.7M1.02B1.11B972.9M751.4M1.07B1.18B990.2M
Pre Tax Income 858M1.08B1.11B1.15B700.7M1.63B1.49B958.1M
Net Income 817.8M968.4M1.01B1.16B722M1.43B1.34B917.7M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 876M1.03B1.13B920.7M751.5M1.07B1.18B999.1M
EBITDA 1.05B1.12B1.22B1.09B865.5M1.19B1.3B1.12B
Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 5.87B6.71B7.86B8.78B16.12B12.26B13.12B14.2B
Operating Income 2.08B2.53B2.21B3.58B8.95B4.74B4.05B3.99B
Pre Tax Income 2.08B2.55B2.43B3.81B9.33B4.86B4.2B4.78B
Net Income 1.2B2.44B2.12B3.51B8.08B4.34B3.95B4.41B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 5.32410.7059.49216.24636.75719.58217.95119.865
EBIT 2.1B2.58B2.34B3.67B9B4.8B4.03B4.01B
EBITDA 2.22B2.68B2.42B3.81B9.23B5.08B4.47B4.47B